The Lupus Foundation of America (LFA) has honored scientists Eric Morand and Joyce Chang for notable contributions to…
Articles by Joana Carvalho, PhD
Excessive production of type I interferon (IFN-I) — a molecule that mediates immune and inflammatory responses — in people…
Oral treatment with cenerimod shows promising safety and efficacy in people with mild to moderate systemic lupus erythematosus (SLE),…
Adding anifrolumab to standard-of-care treatment significantly reduced disease activity, corticosteroid use, and severity of skin lesions in people…
The U.S. Food and Drug Administration (FDA) has granted the designation of breakthrough therapy to…
Autoantibodies targeting certain regulatory RNAs — molecules that serve as the template for protein production — in the brains of…
An international panel of experts on lupus has defined key issues that need to be overcome — with disease…
Scientists have found a new set of biomarkers that may be used to predict the risk of heart disease…
Gazyva (obinutuzumab) in combination with standard-of-care agents significantly increases the percentage of patients with proliferative lupus nephritis…
Platelet-bound C4d (PC4d), one of Exagen‘s patented biomarkers, may be used along with other available biomarkers to estimate…